IRIS
DANIELI, Maria Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.272
EU - Europa 1.884
AS - Asia 462
AF - Africa 70
OC - Oceania 4
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.203
IT - Italia 410
UA - Ucraina 372
IE - Irlanda 237
SE - Svezia 210
DE - Germania 198
SG - Singapore 163
DK - Danimarca 137
CN - Cina 124
GB - Regno Unito 109
FI - Finlandia 84
TR - Turchia 78
KR - Corea 72
CA - Canada 68
FR - Francia 66
CI - Costa d'Avorio 33
MA - Marocco 33
IN - India 19
RU - Federazione Russa 19
BE - Belgio 14
NL - Olanda 11
AT - Austria 4
AU - Australia 4
RS - Serbia 4
EU - Europa 3
PL - Polonia 3
AR - Argentina 2
BR - Brasile 2
CH - Svizzera 2
ID - Indonesia 2
TW - Taiwan 2
UG - Uganda 2
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
HK - Hong Kong 1
MD - Moldavia 1
NG - Nigeria 1
PH - Filippine 1
RO - Romania 1
Totale 5.699
Salva come PNG Salva come JPEG
Città #
Jacksonville 389
Chandler 388
Fairfield 257
Dublin 231
Boardman 227
Ashburn 222
Wilmington 147
Woodbridge 144
New York 115
Ann Arbor 97
Seattle 97
Houston 93
Lawrence 87
Princeton 87
Des Moines 82
San Mateo 82
Cambridge 66
Montréal 62
Centro 59
Singapore 52
Mcallen 49
Munich 44
San Diego 41
Abidjan 33
Turin 28
Washington 23
Beijing 22
Helsinki 19
Milan 18
Los Angeles 17
Pune 17
Redmond 16
Brussels 13
Wuhan 13
Saint Petersburg 12
Shanghai 12
Ancona 11
Castelfidardo 11
Norwalk 10
Dallas 9
London 9
Chiaravalle 8
Guangzhou 8
Kilburn 8
Palermo 7
Rome 6
Rotella 5
Alghero 4
Auburn Hills 4
Belgrade 4
Bergamo 4
Brescia 4
Chiswick 4
Falls Church 4
Genoa 4
Iesi 4
Jiaxing 4
Montemarciano 4
Naples 4
Porto 4
Tolentino 4
Vallefoglia 4
Aarhus 3
Catania 3
Fano 3
Florence 3
Frankfurt am Main 3
Groningen 3
Lecce 3
Monza 3
Ottawa 3
Palm Beach Gardens 3
Prescot 3
Ronciglione 3
Shenzhen 3
Sydney 3
Vienna 3
Warsaw 3
Aurora 2
Bensalem 2
Buenos Aires 2
Cedar Knolls 2
Cerveteri 2
Civitanova Marche 2
Clifton 2
Copertino 2
Dracut 2
Falerone 2
Fayetteville 2
Filottrano 2
Hanover 2
Islington 2
Jesi 2
Jinhua 2
Kampala 2
Macerata 2
Magenta 2
Mergo 2
Mountain View 2
Nizhniy Novgorod 2
Totale 3.605
Salva come PNG Salva come JPEG
Nome #
Prurigo nodularis as the first manifestation of a common variable immunodeficiency 298
Colonna vertebrale. Midollo spinale. Imaging 143
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITHOUT OVERT NEUROPSYCHIATRIC MANIFESTATIONS 101
The EuroMyositis registry: An international collaborative tool to facilitate myositis research 99
La scelta della maternità. Una guida alla decisione per le donne con LES 97
Clinical features and follow-up in patients with 22q11.2 deletion syndrome. 96
Cardiac involvement in polymyositis and dermatomyositis 96
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 95
Subcutaneous IgG in the Myositis Spectrum Disorders 88
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. 83
A Case of CVID-Associated Inflammatory Bowel Disease with CTLA-4 Mutation Treated with Abatacept 83
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 82
The ten-year follow-up data of the Euro-lupus Nephritis Trial comparing low-dose versus high-dose intravenous cyclophosphamide. 81
7th International Immunoglobulin Conference: Immunomodulation. 79
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 77
Overexpression of the cytokine BAFF and autoimmunity risk 76
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies 75
Incidence of malignancy in patients with common variable immunodeficiency according to therapeutic delay: an Italian retrospective, monocentric cohort study 75
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. 75
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 73
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019) 73
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: Results from the MAINTAIN Nephritis Trial 72
IMMUNOSUPPRESSIVE THERAPY IN LUPUS NEPHRITIS: A RANDOMISED TRIAL OF LOW DOSE VERSUS HIGH DOSE INTRAVENOUS CYCLOPHOSPHAMIDE. THE EUROLUPUS NEPHRITIS TRIAL. 71
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 70
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 69
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 69
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. 69
6th International Immunoglobulin Symposium: poster presentations. 68
A proteinuria cut-off level of 0.7 g /day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: Data from the MAINTAIN Nephritis Trial 68
La terapia immunosoppressiva nelle miositi refratttarie 66
Risk factors for Sjögren's syndrome: a case-control study. 66
Dr. Guerra, et al reply 66
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. 65
Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency 65
Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. 64
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. 63
Association tests with systemic lupus erythematosus (SLE) of IL10 arkers indicate a direct involvement of a CA repeat in the 5' regulatory region 62
Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration 62
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 62
Autoimmunità, Gravidanza, Contraccezione, Terapia ormonale 61
Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes 61
Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. 61
Autoimmune thyroid diseases in patients with undifferentiated connective tissue disease. 60
Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein. 59
la terapia con immunoglobuline endovena nel trattamento delle malattie autoimmuni 59
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. 58
Bullous SLE: response to methotrexate and relationship with disease activity 58
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. 57
Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. 56
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial 56
Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis. 55
Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. 54
Subcutaneous immunoglobulins in ocular myositis. 54
Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus 54
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis 53
Systemic lupus in Europe at the change of the millennium: lessons from the "Euro-lupus Project" 53
Recurrent myelitis in common variable immunodeficiency successfully managed with high-dose subcutaneous immunoglobulin. 52
Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review. 52
Autoimmunità Gravidanza Contraccezione Terapia Ormonale 52
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 52
Potential Anti-Tumor Activity of Intravenous and Subcutaneous Immunoglobulin 51
Preliminary report on the use of subcutaneous immunoglobulin in severe inflammatory myopathies 51
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases. 50
Ultrasonographic contrast-enhanced study of sicca syndrome 50
The European Society for Immunodeficiencies (ESID) registry 2014 50
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis. 49
Intravenous Immunoglobulin and Mycophenolate Mofetil for Long-Standing Sensory Neuronopathy in Sjögren's Syndrome 49
Sinchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis. 49
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations 49
Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagnaet al 48
High-dose Facilitated subcutaneous Immunoglobulin in a Patient with refractory Polymyositis and severe Interstitial Lung disease 47
Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. 44
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. 43
Splenic microcalcifications in systemic lupus erythematosus 42
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 42
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 41
Immunoglobulin Treatment inPolymyositis and Dermatomyositis 39
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease 39
Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus. 38
Subcutaneous immunoglobulin G in idiopathic inflammatory myopathies: therapeutic implications. 37
Lessons from the "Euro-Lupus Cohort". 37
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 37
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 37
Valutazione obbiettiva strutturata della competenza clinica (osce) 36
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis 36
Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. 34
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 30
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies. 30
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 28
Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination 28
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies 26
Alarmins in autoimmune diseases 25
Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies 21
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study 17
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 15
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency 15
[Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination] 13
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis 13
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics 13
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 9
Totale 5.827
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.725
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020556 0 0 0 30 115 57 112 11 86 3 36 106
2020/20211.137 66 114 141 5 154 58 131 60 120 87 134 67
2021/2022674 29 176 15 34 3 35 45 58 46 44 74 115
2022/20231.263 104 115 99 104 104 169 5 82 324 13 99 45
2023/2024921 160 40 56 126 144 188 18 34 10 32 19 94
2024/2025384 135 171 76 2 0 0 0 0 0 0 0 0
Totale 5.848